MiR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Gong, Ai Yu ^a   Eischeid, Alex N ^a   Xiao, Jing ^a   Zhao, Jian ^a,b   Chen, Dongqing ^a   Wang, Zhao Yi ^a   Young, Charles Y F ^c   Chen, Xian Ming ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

^c Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; HISTONE ACETYLTRANSFERASE PCAF; MESSENGER RNA; MICRORNA; MICRORNA 17 5P; PROSTATE SPECIFIC ANTIGEN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CARCINOGENESIS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRACELLULAR SIGNALING; MALE; PROSTATE CANCER; PROSTATE SPECIFIC ANTIGEN GENE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; RNA DEGRADATION; RNA TRANSLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; DIHYDROTESTOSTERONE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICRORNAS; P300-CBP TRANSCRIPTION FACTORS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84867686625     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-492     Document Type: Article

References (29)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96. 10.3322/CA.2007.0010, 18287387.
2. Culig Z, Bartsch G. Androgen axis in prostate cancer. J Cell Biochem 2006, 99:373-381. 10.1002/jcb.20898, 16598769.
3. Lamont KR, Tindall DJ. Androgen regulation of gene expression. Adv Cancer Res 2010, 107:137-162.
4. Debes JD, Tindall DJ. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 2004, 351:1488-1490. 10.1056/NEJMp048178, 15470210.
5. Gao L, Alumkal J. Epigenetic regulation of androgen receptor signaling in prostate cancer. Epigenetics 2010, 5:100-104. 10.4161/epi.5.2.10778, 3150559, 20160483.
6. Nagy ZL, Tora L. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 2007, 26:5341-5357. 10.1038/sj.onc.1210604, 17694077.
7. Chmelar R, Buchanan G, Need EF, Tilley W, Greenberg NM. Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. Int J Cancer 2007, 120:719-733. 10.1002/ijc.22365, 17163421.
8. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297. 10.1016/S0092-8674(04)00045-5, 14744438.
9. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genetics 2010, 11:597-610.
10. Lujambio A, Lowe SW. The microcosmos of cancer. Nature 2012, 482:347-355. 10.1038/nature10888, 3509753, 22337054.
11. Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012, 4:143-159. 10.1002/emmm.201100209, 3376845, 22351564.
12. Kasinski AL, Slack FJ. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 2011, 11:849-864. 10.1038/nrc3166, 22113163.
13. Corsini LR, Bronte G, Terrasi M, Amodeo V, Fanale D, Fiorentino E, Cicero G, Bazan V, Russo A. The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies. Expert Opin Ther Targets 2012, 16:S103-S109.
14. Sevli S, Uzumcu A, Solak M, Ittmann M, Ozen M. The function of microRNAs, small but potent molecules, in human prostate cancer. Prostate Cancer Prostatic Dis 2010, 13:208-217. 10.1038/pcan.2010.21, 20585343.
15. Liu C, Kelnar K, Liu B, Chen X, Calhoun-Davis T, Li H, Patrawala L, Yan H, Jeter C, Honorio S, Wiggins JF, Bader AG, Fagin R, Brown D, Tang DG. The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. Nat Med 2011, 17:211-215. 10.1038/nm.2284, 3076220, 21240262.
16. Maugeri-Saccà M, Coppola V, Bonci D, De Maria R. MicroRNAs and prostate cancer: from preclinical research to translational oncology. Cancer J 2012, 18:253-261. 10.1097/PPO.0b013e318258b5b6, 22647362.
17. Triboulet R, Mari B, Lin YL, Chable-Bessia C, Bennasser Y, Lebrigand K, Cardinaud B, Maurin T, Barbry P, Baillat V, Reynes J, Corbeau P, Jeang KT, Benkirane M. Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 2007, 315:1579-1582. 10.1126/science.1136319, 17322031.
18. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006, 103:2257-2261. 10.1073/pnas.0510565103, 1413718, 16461460.
19. Sikand K, Slane SD, Shukla GC. Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int 2009, 9:21. 10.1186/1475-2867-9-21, 2739157, 19674469.
20. Zhang X, Ladd A, Dragoescu E, Budd WT, Ware JL, Zehner ZE. MicroRNA-17-3p is a prostate tumor suppressor in vitro and in vivo, and is decreased in high grade prostate tumors analyzed by laser capture microdissection. Clin Exp Metastasis 2009, 26:965-979. 10.1007/s10585-009-9287-2, 19771525.
21. Gong AY, Hu G, Zhou R, Liu J, Feng Y, Soukup GA, Chen XM. MicroRNA-221 controls expression of intercellular adhesion molecule-1 in epithelial cells in response to Cryptosporidium parvum infection. Int J Parasitol 2011, 41:397-403. 10.1016/j.ijpara.2010.11.011, 3046242, 21236259.
22. Gong AY, Zhou R, Hu G, Liu J, Sosnowska D, Drescher KM, Dong H, Chen XM. Cryptosporidium parvum induces B7-H1 expression in cholangiocytes by downregulating microRNA-513. J Infect Dis 2010, 201:160-169. 10.1086/648589, 2791176, 19916867.
23. Gaughan L, Logan IR, Neal DE, Robson CN. Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation. Nucleic Acids Res 2005, 33:13-26. 10.1093/nar/gki141, 546130, 15640443.
24. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007, 449:919-922. 10.1038/nature06205, 2748825, 17943132.
25. Gong AY, He M, Krishna Vanaja D, Yin P, Karnes RJ, Young CY. Phenethyl isothiocyanate inhibits STAT3 activation in prostate cancer cells. Mol Nutr Food Res 2009, 53:878-886. 10.1002/mnfr.200800253, 19437484.
26. Yuan H, Young CY, Tian Y, Liu Z, Zhang M, Lou H. Suppression of the androgen receptor function by quercetin through protein-protein interactions of Sp1, c-Jun, and the androgen receptor in human prostate cancer cells. Mol Cell Biochem 2010, 339:253-262. 10.1007/s11010-010-0388-7, 20148354.
27. Miyajima N, Maruyama S, Bohgaki M, Kano S, Shigemura M, Shinohara N, Nonomura K, Hatakeyama S. TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells. Cancer Res 2008, 68:3486-3494. 10.1158/0008-5472.CAN-07-6059, 18451177.
28. Fu M, Wang C, Reutens AT, Angelletti R, Siconolfi-Baez L, Ogryzko V, Avantaggiati ML, Pestell RG. p300 and P/CAF acetylate the androgen receptor at sites governing hormone-dependent transactivation. J Biol Chem 2000, 275:20853-20860. 10.1074/jbc.M000660200, 10779504.
29. Reutens AT, Fu M, Wang C, Albanese C, McPhaul MJ, Sun Z, Balk SP, Jänne OA, Palvimo JJ, Pestell RG. Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. Mol Endocrinol 2001, 15:797-811. 10.1210/me.15.5.797, 11328859.